[123I]β-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls

This publication has 13 references indexed in Scilit:

• Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
  1996
• [sup 123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease
  Neurology, 1996
• Decreased dopamine transporters with age in healthy human subjects
  Annals of Neurology, 1994
• Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
  Proceedings of the National Academy of Sciences, 1993
• AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
  Brain, 1991
• Age‐related changes in the human nigrostriatal dopaminergic system
  Annals of Neurology, 1990
• Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen
  Neurobiology of Aging, 1989
• Monoamine re-uptake sites in the human brain evaluatedin vivoby means of¹¹C-nomifensine and positron emission tomography: the effects of age and Parkinson's disease
  Acta Neurologica Scandinavica, 1988
• Decreased density of human striatal dopamine uptake sites with age
  European Journal of Pharmacology, 1986